BEUDAMED
    26 results · 27ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    WHOOP, Inc.

    Manufacturer
    🇺🇸 United States

    Whoop, Inc.

    FDA registration
    Whoop, Inc.·1 product·🇺🇸 United States

    WHOOP ECG Feature

    FDA UDI
    Whoop, Inc.·00860012964819·

    WHOOP 4.0

    FDA Adverse Event
    Injury ·WHOOP, INC.·Product code QDA·October 20, 2025

    WHOOP BAND

    FDA Adverse Event
    Injury ·WHOOP INC.·Product code QDA·February 24, 2026

    Emergo Europe B.V.

    Authorized representative
    🇳🇱 Netherlands·900 Manufacturers·22100 Devices

    SURGICEL ABSORBABLE HEMOSTAT

    FDA Adverse Event
    Injury ·ETHICON, INC.·Product code LMG·June 15, 2005

    VICRYL POLYGLACTIN 910 SUTURE

    FDA Adverse Event
    Injury ·ETHICON INC.·Product code GAM·March 17, 2015

    VICRYL POLYGLACTIN 910 SUTURE

    FDA Adverse Event
    Injury ·ETHICON INC.·Product code GAM·March 17, 2015

    COATED VICRYL (POLYGLACTIN 910) SUTURE

    FDA Adverse Event
    Injury ·ETHICON, INC.·Product code GAM·January 9, 2006

    ULTRAPRO HERNIA SYSTEM

    FDA Adverse Event
    Injury ·ETHICON INC.·Product code FTL·August 13, 2014

    ADVANTAGE FIT SYSTEM

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC - MARLBOROUGH·Product code FTL·October 11, 2012

    VICRYL PLUS POLYGLACTIN 910 SUTURE

    FDA Adverse Event
    Injury ·ETHICON INC.·Product code GAM·July 7, 2015

    Stryker Neurovascular, AXS Vecta 74 Aspiration Catheter, Ref. Catalog No. INC-11597-115, Use By 2021-11-29, Rx Only, Sterile/EO, Manufactured For: Stryker Neurovascular 47900 Bayside Parkway, Fremont, CA 94538, UDI: (01)07613327459241(17)211129(10)00000-00 Stryker Neurovascular, AXS Vecta 74 Aspiration Catheter, Ref. Catalog No. INC-11597-125, Use By 2021-11-29, Rx Only, Sterile/EO, Manufactured For: Stryker Neurovascular 47900 Bayside Parkway, Fremont, CA 94538, UDI: (01)07613327459258(17)211129(10)00000-00 Stryker Neurovascular, AXS Vecta 74 Aspiration Catheter, Ref. Catalog No. INC-11597-132, Use By 2021-11-29, Rx Only, Sterile/EO, Manufactured For: Stryker Neurovascular 47900 Bayside Parkway, Fremont, CA 94538, UDI: (01)07613327459265(17)211129(10)00000-00 Product Usage: The AXS Vecta Aspiration System, including the AXS Vecta Aspiration Catheter, Aspiration Tubing Set, and VC-701 Cliq Aspirator Pump, is indicated in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who failed IV t-PA therapy are candidates for treatment.

    FDA Enforcement
    Class II ·Terminated·Stryker Neurovascular·April 8, 2020

    SOLYX SIS SYSTEM

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC - MARLBOROUGH·Product code FTL·April 11, 2013

    Stryker Neurovascular, AXS Vecta 71 Aspiration Catheter, Ref. Catalog No. INC-11129-115, Use By 2021-11-29, Rx Only, Sterile/EO, Manufactured For: Stryker Neurovascular 47900 Bayside Parkway, Fremont, CA 94538, UDI: (01)07613327459210(17)211129(10)00000-00 Stryker Neurovascular, AXS Vecta 71 Aspiration Catheter, Ref. Catalog No. INC-11129-125, Use By 2021-11-29, Rx Only, Sterile/EO, Manufactured For: Stryker Neurovascular 47900 Bayside Parkway, Fremont, CA 94538, UDI: (01)07613327459227(17)211129(10)00000-00 Stryker Neurovascular, AXS Vecta 71 Aspiration Catheter, Ref. Catalog No. INC-11129-132, Use By 2021-11-29, Rx Only, Sterile/EO, Manufactured For: Stryker Neurovascular 47900 Bayside Parkway, Fremont, CA 94538, UDI: (01)07613327459234(17)211129(10)00000-00 Product Usage: The AXS Vecta Aspiration System, including the AXS Vecta Aspiration Catheter, Aspiration Tubing Set, and VC-701 Cliq Aspirator Pump, is indicated in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who failed IV t-PA therapy are candidates for treatment.

    FDA Enforcement
    Class II ·Terminated·Stryker Neurovascular·April 8, 2020

    MESH, SURGICAL, POLYMERIC

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC - MARLBOROUGH·Product code FTL·December 15, 2011

    SECURESTRAP 5MM ABSORBABLE STRAP FIXATION DEVICE

    FDA Adverse Event
    Injury ·ETHICON INC.·Product code GDW·March 11, 2015

    GYNECARE PROLIFT POSTERIOR PELVIC FLOOR REPAIR SYSTEM

    FDA Adverse Event
    Injury ·ETHICON INC.·Product code OTP·March 4, 2015

    ENTERRA

    FDA Adverse Event
    Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LNQ·July 2, 2019